Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Aug 15;366(Pt 1):145–155. doi: 10.1042/BJ20020527

Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not.

Ahmed A A Mohamed 1, Orla J Jupp 1, Helen M Anderson 1, Alison F Littlejohn 1, Peter Vandenabeele 1, David J MacEwan 1
PMCID: PMC1222751  PMID: 11996667

Abstract

The activation of the extracellular signal-regulated kinases (ERKs) by tumour necrosis factor-alpha (TNF) receptors (TNFRs) is an integral part of the cytokine's pleiotropic cellular responses. Here we report differences in the caspase sensitivity and TNFR subtype activation of members of the ERK family. Inhibition in HeLa cells of caspase function by pharmacological inhibitors or the expression of CrmA (cytokine response modifier A), a viral modifier protein, blocks TNF-induced apoptosis or caspase-dependent protein kinase Cdelta and poly(ADP-ribose) polymerase protein degradation. TNFR1- or TNFR2-stimulated c-Jun N-terminal kinase (JNK) activity was attenuated in cells in which caspase activity was inhibited either by pharmacological blockers or CrmA expression. Both TNFR1- and TNFR2-stimulated JNK activity was caspase-sensitive; however, only TNFR1 was capable of stimulating p42/44 mitogen-activated protein kinase (MAPK) and p38 MAPK activities. TNFR1-stimulated p42/44 MAPK and p38 MAPK activities were insensitive to pharmacological caspase inhibition or CrmA. These findings were supported when measuring TNF-induced cytosolic phospholipase A(2) activation, which is a downstream target for MAPK and p38 MAPK. Profiling caspase enzymes activated by TNF in HeLa cells showed sequential caspase-8, -3, -7, -6 and -9 activation, with their inhibition characteristics suggesting a role for caspase-3 and/or caspase-6 in modulating JNK activity. Taken together these results show delineated ERK-activation pathways employed by TNFR subtypes.

Full Text

The Full Text of this article is available as a PDF (497.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggarwal B. B. Apoptosis and nuclear factor-kappa B: a tale of association and dissociation. Biochem Pharmacol. 2000 Oct 15;60(8):1033–1039. doi: 10.1016/s0006-2952(00)00393-2. [DOI] [PubMed] [Google Scholar]
  2. Ashkenazi A., Dixit V. M. Death receptors: signaling and modulation. Science. 1998 Aug 28;281(5381):1305–1308. doi: 10.1126/science.281.5381.1305. [DOI] [PubMed] [Google Scholar]
  3. Assefa Z., Vantieghem A., Declercq W., Vandenabeele P., Vandenheede J. R., Merlevede W., de Witte P., Agostinis P. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J Biol Chem. 1999 Mar 26;274(13):8788–8796. doi: 10.1074/jbc.274.13.8788. [DOI] [PubMed] [Google Scholar]
  4. Baxter G. T., Kuo R. C., Jupp O. J., Vandenabeele P., MacEwan D. J. Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J Biol Chem. 1999 Apr 2;274(14):9539–9547. doi: 10.1074/jbc.274.14.9539. [DOI] [PubMed] [Google Scholar]
  5. Bemelmans M. H., van Tits L. J., Buurman W. A. Tumor necrosis factor: function, release and clearance. Crit Rev Immunol. 1996;16(1):1–11. doi: 10.1615/critrevimmunol.v16.i1.10. [DOI] [PubMed] [Google Scholar]
  6. Bigda J., Beletsky I., Brakebusch C., Varfolomeev Y., Engelmann H., Bigda J., Holtmann H., Wallach D. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J Exp Med. 1994 Aug 1;180(2):445–460. doi: 10.1084/jem.180.2.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bonizzi G., Piette J., Schoonbroodt S., Merville M. P., Bours V. Role of the protein kinase C lambda/iota isoform in nuclear factor-kappaB activation by interleukin-1beta or tumor necrosis factor-alpha: cell type specificities. Biochem Pharmacol. 1999 Mar 15;57(6):713–720. doi: 10.1016/s0006-2952(98)00353-0. [DOI] [PubMed] [Google Scholar]
  8. Brenner B., Ferlinz K., Grassmé H., Weller M., Koppenhoefer U., Dichgans J., Sandhoff K., Lang F., Gulbins E. Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases. Cell Death Differ. 1998 Jan;5(1):29–37. doi: 10.1038/sj.cdd.4400307. [DOI] [PubMed] [Google Scholar]
  9. Cardone M. H., Salvesen G. S., Widmann C., Johnson G., Frisch S. M. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell. 1997 Jul 25;90(2):315–323. doi: 10.1016/s0092-8674(00)80339-6. [DOI] [PubMed] [Google Scholar]
  10. Cohen G. M. Caspases: the executioners of apoptosis. Biochem J. 1997 Aug 15;326(Pt 1):1–16. doi: 10.1042/bj3260001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cross T. G., Scheel-Toellner D., Henriquez N. V., Deacon E., Salmon M., Lord J. M. Serine/threonine protein kinases and apoptosis. Exp Cell Res. 2000 Apr 10;256(1):34–41. doi: 10.1006/excr.2000.4836. [DOI] [PubMed] [Google Scholar]
  12. Decoster E., Vanhaesebroeck B., Vandenabeele P., Grooten J., Fiers W. Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor. J Biol Chem. 1995 Aug 4;270(31):18473–18478. doi: 10.1074/jbc.270.31.18473. [DOI] [PubMed] [Google Scholar]
  13. Denecker G., Vercammen D., Declercq W., Vandenabeele P. Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci. 2001 Mar;58(3):356–370. doi: 10.1007/PL00000863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ekert P. G., Silke J., Vaux D. L. Caspase inhibitors. Cell Death Differ. 1999 Nov;6(11):1081–1086. doi: 10.1038/sj.cdd.4400594. [DOI] [PubMed] [Google Scholar]
  15. Ekert P. G., Silke J., Vaux D. L. Inhibition of apoptosis and clonogenic survival of cells expressing crmA variants: optimal caspase substrates are not necessarily optimal inhibitors. EMBO J. 1999 Jan 15;18(2):330–338. doi: 10.1093/emboj/18.2.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fiers W., Beyaert R., Declercq W., Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene. 1999 Dec 16;18(54):7719–7730. doi: 10.1038/sj.onc.1203249. [DOI] [PubMed] [Google Scholar]
  17. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 1991 Jul 22;285(2):199–212. doi: 10.1016/0014-5793(91)80803-b. [DOI] [PubMed] [Google Scholar]
  18. Grell M., Douni E., Wajant H., Löhden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 1995 Dec 1;83(5):793–802. doi: 10.1016/0092-8674(95)90192-2. [DOI] [PubMed] [Google Scholar]
  19. Haridas V., Darnay B. G., Natarajan K., Heller R., Aggarwal B. B. Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation. J Immunol. 1998 Apr 1;160(7):3152–3162. [PubMed] [Google Scholar]
  20. Hayakawa M., Ishida N., Takeuchi K., Shibamoto S., Hori T., Oku N., Ito F., Tsujimoto M. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem. 1993 May 25;268(15):11290–11295. [PubMed] [Google Scholar]
  21. Heller R. A., Song K., Fan N., Chang D. J. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell. 1992 Jul 10;70(1):47–56. doi: 10.1016/0092-8674(92)90532-h. [DOI] [PubMed] [Google Scholar]
  22. Helms M. J., Mohamed A. A., MacEwan D. J. Modulated kinase activities in cells undergoing tumour necrosis factor-induced apoptotic cell death. FEBS Lett. 2001 Sep 7;505(1):68–74. doi: 10.1016/s0014-5793(01)02779-x. [DOI] [PubMed] [Google Scholar]
  23. Jones B. E., Lo C. R., Liu H., Srinivasan A., Streetz K., Valentino K. L., Czaja M. J. Hepatocytes sensitized to tumor necrosis factor-alpha cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways. J Biol Chem. 2000 Jan 7;275(1):705–712. doi: 10.1074/jbc.275.1.705. [DOI] [PubMed] [Google Scholar]
  24. Jupp O. J., McFarlane S. M., Anderson H. M., Littlejohn A. F., Mohamed A. A., MacKay R. H., Vandenabeele P., MacEwan D. J. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways. Biochem J. 2001 Nov 1;359(Pt 3):525–535. doi: 10.1042/0264-6021:3590525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kilpatrick L. E., Song Y. H., Rossi M. W., Korchak H. M. Serine phosphorylation of p60 tumor necrosis factor receptor by PKC-delta in TNF-alpha-activated neutrophils. Am J Physiol Cell Physiol. 2000 Dec;279(6):C2011–C2018. doi: 10.1152/ajpcell.2000.279.6.C2011. [DOI] [PubMed] [Google Scholar]
  26. Kramer R. M., Roberts E. F., Um S. L., Börsch-Haubold A. G., Watson S. P., Fisher M. J., Jakubowski J. A. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem. 1996 Nov 1;271(44):27723–27729. doi: 10.1074/jbc.271.44.27723. [DOI] [PubMed] [Google Scholar]
  27. Laouar A., Glesne D., Huberman E. Involvement of protein kinase C-beta and ceramide in tumor necrosis factor-alpha-induced but not Fas-induced apoptosis of human myeloid leukemia cells. J Biol Chem. 1999 Aug 13;274(33):23526–23534. doi: 10.1074/jbc.274.33.23526. [DOI] [PubMed] [Google Scholar]
  28. Lee J. Y., Hannun Y. A., Obeid L. M. Functional dichotomy of protein kinase C (PKC) in tumor necrosis factor-alpha (TNF-alpha ) signal transduction in L929 cells. Translocation and inactivation of PKC by TNF-alpha. J Biol Chem. 2000 Sep 22;275(38):29290–29298. doi: 10.1074/jbc.M000170200. [DOI] [PubMed] [Google Scholar]
  29. Leeuwenberg J. F., van Tits L. J., Jeunhomme T. M., Buurman W. A. Evidence for exclusive role in signalling of tumour necrosis factor p55 receptor and a potentiating function of p75 receptor on human endothelial cells. Cytokine. 1995 Jul;7(5):457–462. doi: 10.1006/cyto.1995.0062. [DOI] [PubMed] [Google Scholar]
  30. Lin L. L., Wartmann M., Lin A. Y., Knopf J. L., Seth A., Davis R. J. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 1993 Jan 29;72(2):269–278. doi: 10.1016/0092-8674(93)90666-e. [DOI] [PubMed] [Google Scholar]
  31. MacEwan David J. TNF ligands and receptors--a matter of life and death. Br J Pharmacol. 2002 Feb;135(4):855–875. doi: 10.1038/sj.bjp.0704549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. McFarlane S. M., Jupp O. J., Cobban H. J., Hunter I., Anderson H. M., Vandenabeele P., Nixon G. F., MacEwan D. J. Stimulation of stress-activated but not mitogen-activated protein kinases by tumour necrosis factor receptor subtypes in airway smooth muscle. Biochem Pharmacol. 2001 Mar 15;61(6):749–759. doi: 10.1016/s0006-2952(01)00530-5. [DOI] [PubMed] [Google Scholar]
  33. Mühlenbeck F., Haas E., Schwenzer R., Schubert G., Grell M., Smith C., Scheurich P., Wajant H. TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways. J Biol Chem. 1998 Dec 4;273(49):33091–33098. doi: 10.1074/jbc.273.49.33091. [DOI] [PubMed] [Google Scholar]
  34. Park J., Kim I., Oh Y. J., Lee K., Han P. L., Choi E. J. Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2. J Biol Chem. 1997 Jul 4;272(27):16725–16728. doi: 10.1074/jbc.272.27.16725. [DOI] [PubMed] [Google Scholar]
  35. Paul A., Wilson S., Belham C. M., Robinson C. J., Scott P. H., Gould G. W., Plevin R. Stress-activated protein kinases: activation, regulation and function. Cell Signal. 1997 Sep;9(6):403–410. doi: 10.1016/s0898-6568(97)00042-9. [DOI] [PubMed] [Google Scholar]
  36. Pollock V. P., Lofthouse E. J., Jupp O. J., Gauld S. B., Anderson H. M., MacEwan D. J. Selective down-regulation of the G(q)alpha/G11alpha G-protein family in tumour necrosis factor-alpha induced cell death. Mol Cell Biochem. 2000 Mar;206(1-2):67–74. doi: 10.1023/a:1007066409645. [DOI] [PubMed] [Google Scholar]
  37. Ray C. A., Black R. A., Kronheim S. R., Greenstreet T. A., Sleath P. R., Salvesen G. S., Pickup D. J. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell. 1992 May 15;69(4):597–604. doi: 10.1016/0092-8674(92)90223-y. [DOI] [PubMed] [Google Scholar]
  38. Roulston A., Reinhard C., Amiri P., Williams L. T. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem. 1998 Apr 24;273(17):10232–10239. doi: 10.1074/jbc.273.17.10232. [DOI] [PubMed] [Google Scholar]
  39. Sanz L., Sanchez P., Lallena M. J., Diaz-Meco M. T., Moscat J. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. EMBO J. 1999 Jun 1;18(11):3044–3053. doi: 10.1093/emboj/18.11.3044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schotte P., Declercq W., Van Huffel S., Vandenabeele P., Beyaert R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 1999 Jan 8;442(1):117–121. doi: 10.1016/s0014-5793(98)01640-8. [DOI] [PubMed] [Google Scholar]
  41. Smith C. A., Farrah T., Goodwin R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 1994 Mar 25;76(6):959–962. doi: 10.1016/0092-8674(94)90372-7. [DOI] [PubMed] [Google Scholar]
  42. Tartaglia L. A., Pennica D., Goeddel D. V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem. 1993 Sep 5;268(25):18542–18548. [PubMed] [Google Scholar]
  43. Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D. R., Poirier G. G., Salvesen G. S., Dixit V. M. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995 Jun 2;81(5):801–809. doi: 10.1016/0092-8674(95)90541-3. [DOI] [PubMed] [Google Scholar]
  44. Vandenabeele P., Declercq W., Beyaert R., Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 1995 Oct;5(10):392–399. doi: 10.1016/s0962-8924(00)89088-1. [DOI] [PubMed] [Google Scholar]
  45. Vandenabeele P., Declercq W., Vanhaesebroeck B., Grooten J., Fiers W. Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol. 1995 Mar 15;154(6):2904–2913. [PubMed] [Google Scholar]
  46. Wajant H., Haas E., Schwenzer R., Muhlenbeck F., Kreuz S., Schubert G., Grell M., Smith C., Scheurich P. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). J Biol Chem. 2000 Aug 11;275(32):24357–24366. doi: 10.1074/jbc.M000811200. [DOI] [PubMed] [Google Scholar]
  47. Weiss T., Grell M., Hessabi B., Bourteele S., Müller G., Scheurich P., Wajant H. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site. J Immunol. 1997 Mar 1;158(5):2398–2404. [PubMed] [Google Scholar]
  48. Weiss T., Grell M., Siemienski K., Mühlenbeck F., Dürkop H., Pfizenmaier K., Scheurich P., Wajant H. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J Immunol. 1998 Sep 15;161(6):3136–3142. [PubMed] [Google Scholar]
  49. Widmann C., Gibson S., Johnson G. L. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem. 1998 Mar 20;273(12):7141–7147. doi: 10.1074/jbc.273.12.7141. [DOI] [PubMed] [Google Scholar]
  50. Xia Y., Makris C., Su B., Li E., Yang J., Nemerow G. R., Karin M. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5243–5248. doi: 10.1073/pnas.97.10.5243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995 Nov 24;270(5240):1326–1331. doi: 10.1126/science.270.5240.1326. [DOI] [PubMed] [Google Scholar]
  52. Zhou Q., Salvesen G. S. Viral caspase inhibitors CrmA and p35. Methods Enzymol. 2000;322:143–154. doi: 10.1016/s0076-6879(00)22014-4. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES